Skip to main navigation Skip to search Skip to main content

Randomized phase II trial of fulvestrant plus everolimus or placebo in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer resistant to aromatase inhibitor therapy: Results of PrE0102

  • Noah Kornblum
  • , Fengmin Zhao
  • , Judith Manola
  • , Paula Klein
  • , Bhuvaneswari Ramaswamy
  • , Adam Brufsky
  • , Phillip J. Stella
  • , Brian Burnette
  • , Melinda Telli
  • , Della F. Makower
  • , Puneet Cheema
  • , Cristina I. Truica
  • , Antonio C. Wolff
  • , Gamini S. Soori
  • , Barbara Haley
  • , Timothy R. Wassenaar
  • , Lori J. Goldstein
  • , Kathy D. Miller
  • , Joseph A. Sparano

Research output: Contribution to journal › Article › peer-review

179   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Randomized phase II trial of fulvestrant plus everolimus or placebo in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer resistant to aromatase inhibitor therapy: Results of PrE0102'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science